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Background: General practitioners (GPs) and nurses are ideally placed to address the significant unmet demand for
the treatment of cannabis-related problems given the numbers of people who regularly seek their care. The aim of
this study was to evaluate differences between GPs and nurses’ perceived knowledge, beliefs, and behaviors toward
cannabis use and its screening and management.
Methods: This study involved 161 nurses and 503 GPs who completed a survey distributed via conference satchels
to delegates of Healthed seminars focused on topics relevant to women and children’s health. Differences between
GPs and nurses were analyzed using χ2- tests and two-sample t-tests, while logistic regression examined predictors
of service provision.
Results: GPs were more likely than nurses to have engaged in cannabis-related service provision, but also more
frequently reported barriers related to time, interest, and having more important issues to address. Nurses reported
less knowledge, skills, and role legitimacy. Perceived screening skills predicted screening and referral to alcohol and
other drug (AOD) services, while knowing a regular user increased the likelihood of referrals only.
Conclusions: Approaches to increase cannabis-related screening and intervention may be improved by involving
nurses, and by leveraging the relationship between nurses and doctors, in primary care.
Keywords: Cannabis, Marijuana abuse, Diagnosis, Therapeutics, Primary health care, AttitudeBackground
Cannabis remains the most commonly used illicit
drug, with around 200 million current users world-
wide [1]. Cannabis use increases the risk of chronic
respiratory and cardiovascular problems [2-5], and
around one in nine users are at risk of developing de-
pendence [6,7]. In Australia, these health risks are of
significant concern given that cannabis use contri-
butes to 10% of the burden relating to illicit drug use
[8]. While few cannabis users seek specialist drug
treatment [9,10], general practitioners (GPs) are the
most frequently sought resource for treatment of can-
nabis use [11]. As approximately 80% of Australians
visit a GP at least once a year [12], primary care* Correspondence: mnorberg@unsw.edu.au
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reproduction in any medium, provided the orprovides substantial opportunity for cannabis use
screening and intervention. Doctors and nurses in
primary care may be able to influence their patients’
cannabis use through a variety of health strategies
[13], but their attitudes, knowledge, and skills may
limit the provision of such care [14,15].
Although primary care practitioners are encouraged
to, and typically believe it is appropriate for them to
screen and provide early interventions for substance use
[16], many do not feel comfortable diagnosing or treat-
ing substance use problems [17-19]. Further, the content
of a typical substance use brief intervention is not well
known [16] and commonly disregarded as ineffective
[18,20]. Many doctors and nurses have reported avoiding
substance use discussions due to anticipated negative
reactions from patients, believing that patients will not
be honest about their substance use, not having enough
training and resources, and time constraints [18,20-22].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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available support services, quick and easy screening
instruments and counseling material, more training, and
evidence of the successful impact for early intervention
would lead to their greater involvement in screening and
intervention [16,20,22].
If more cannabis screening and intervention were to
occur within primary care, a key question is whether
nurses or GPs could more feasibly undertake this work.
While nurses may be less subject to the time constraints
for opportunistic intervention that doctors experience
[23,24], findings from the alcohol literature indicate that
nurses compared to GPs have less knowledge and skills
about screening and intervention [16,25], have less fa-
vorable attitudes towards discussing substance use with
their patients [16], and are less likely to believe that this
work should be a part of their role [16]. In addition,
qualitative research found that nurses can be hesitant to
provide alcohol interventions because of their own use
and enjoyment of alcohol and because of their beliefs
that alcohol use may serve beneficial social and coping
functions for some patients [21]. If these alcohol-related
findings are transferrable to cannabis use, they suggest
that nurses may be less inclined than GPs to screen for
cannabis use and provide early intervention.
While a modest amount of research has examined
GP’s and nurses’ attitudes towards alcohol and substance
use in general, relatively little has focused specifically on
cannabis use. In a UK survey of 97 GPs, most believed
that cannabis use posed a health risk and may lead to
mental health problems, but less than half believed that
they had adequate knowledge about cannabis use, and
only a third felt confident in their ability to advise
patients about their cannabis use [22]. In addition,
around half believed that GPs should refer patients with
cannabis-related problems to specialist drug services,
with only a third believing it was appropriate to treat
cannabis dependence in primary care. GPs who believed
it was appropriate to treat cannabis dependence in pri-
mary care felt more confident in their ability to advise
cannabis-using patients, whereas GPs who believed
cannabis-using patients should be referred to specialist
drug services reported a greater need to improve their
knowledge of cannabis-related risks.
The aim of this study was to assess potential differ-
ences between GPs and nurses. Based on findings
reviewed above, we hypothesized that while few GPs and
nurses would be confident in their knowledge and skills
about cannabis use and its treatment, nurses would re-
port having less training (Hypothesis 1) and less role le-
gitimacy for screening and treating cannabis use
(Hypothesis 2), and perceive their knowledge and skills
to be poorer than GPs (Hypothesis 3). In addition, we
hypothesized that GP’s and nurses’ training, personalexperience, knowledge, attitudes, and beliefs would be
related to whether or not they engaged in screening or
intervention for cannabis use (Hypothesis 4).Methods
Participants
The study sample was comprised of delegates attend-
ing a Healthed seminar in one of five Australian cities
(Sydney, Melbourne, Adelaide, Brisbane, and Perth) in
2011. Each Healthed seminar featured approximately
sixteen lectures on women and children’s health and
represented a rare opportunity to meet with several hun-
dred GPs and nurses in one location. GPs and nurses
received professional education points for attending the
lectures. Of the 1,925 delegates who attended the
Healthed seminars, 664 (35%) completed the study sur-
vey; 503 surveys were completed by GPs (76%) and 162
were completed by nurses (24%). This distribution was
representative of the Healthed population, in which 71%
were GPs and 26% were nurses. The study sample was
predominately female (n= 527, 79%), which again reflects
the Healthed population, as only 41% of Australian GPs
are female [26]. The sample had a mean age of 48 years
(SD= 9.88, range 21-81) and most practiced in a metro-
politan area (n= 463, 71%). GPs were significantly more
likely to be male (27% vs. <1%; χ2(1) = 51.23, p< 0.001),
and younger (GPs Mage= 47.61 years, SD= 10.25; nurse’s
Mage= 49.93 years, SD= 8.04; t(343.77) = -2.95, p= 0.003),
and reported spending significantly more hours in the
clinic per week than did nurses (GP Mhours= 30.45, SD=
12.65; nurse’s Mhours= 26.56, SD= 12.04; t(646) = 3.35,
p= 0.001.
Data collection
During the opening of each Healthed seminar, we
informed delegates that the survey and its information
and consent form were located in their conference
satchel. We advised delegates that if they were interested
in participating that they should complete the entire
self-report survey, as item nonresponse would render
their survey invalid given the brevity of the survey. We
instructed delegates to turn in their surveys, before after-
noon tea, into dropboxes at the conference. Lastly, we
instructed delegates that participation would result in
entry into a lottery held during afternoon tea to win one
of five gift certificates ($75 AUD). These procedures re-
flect a cross-sectional design.
Survey
The survey was devised primarily for use in this study,
and thus, had not been psychometrically validated. The
survey had 31 items; of which 25 were relevant to the
current study. Five items addressed basic demographic
Table 1 Exposure to Cannabis Use
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practice, and weekly clinical hours), and two items cov-
ered exposure to cannabis issues (relevant training and
personal experience with a regular cannabis user). Five
items assessed knowledge regarding cannabis use (e.g.,
Cannabis users are more likely to have a mental health
problem than those who do not use cannabis); four of
these items were rated on a Likert scale from 0 (disagree
completely) to 4 (agree completely). The fifth knowledge
item was answered with a percentage (What percentage
of people who try cannabis will someday develop canna-
bis dependence?).
The remaining 13 items used in this study were based
on previous surveys assessing health practitioners’
beliefs, attitudes, and behavior regarding substance use
and its treatment. Three items required GPs and nurses
to assess their own knowledge about cannabis use and
their skills related to screening and managing cannabis
use [16–18,27]. These three items were rated on a Likert
scale from 0 (very poor) to 4 (very strong). In addition,
three items assessed beliefs regarding role legitimacy—
factors related to the appropriateness of a GP or nurse
to intervene with someone’s cannabis use [21,25,27,28]
and were rated on a Likert scale from 0 (disagree com-
pletely) to 4 (agree completely). One item assessed atti-
tudes regarding cannabis use policy (Cannabis use
should be illegal / decriminalized / available for med-
ical use) [22,29]. Four open-ended items assessed behav-
ior related to screening, intervention, and referral
[22,28,30]. Participants responded to these items with
numbers (e.g., I have screened ____ patients for cannabis
use in the last month). The final two items assessed bar-
riers and facilitators to screening and treatment provision
[18,20,25,27-29]. These items were answered by checking
all applicable barriers or facilitators. Options referred to
attitudes, motivation, confidence, and support.Item n GPs Nurses χ (1)
n (%) n (%)
Cannabis Related Training 660
None 132 (27%) 66 (41%) 12.26**
Small Amount 300 (60%) 77 (48%) 7.51*
Moderate Amount 60 (12%) 17 (11%) 0.25
Substantial Amount 7 (1%) 1 (<1%) 0.62
Great Deal 0 (0%) 0 (0%) –
Cannabis users known to
participantsa
657
No one 331 (67%) 68 (43%) 28.48**
Relative (other than child) 43 (9%) 35 (22%) 20.23**
Child 13 (3%) 7 (4%) 1.27
Friend 129 (26%) 65 (41%) 12.52**
Self 1 (<1%) 0 (0%) 0.32
Note. aPercentages do not add up to 100% as some participants choose more
than one response option.
*p< 0.01, **p≤ 0.001.Statistical analyses
Differences between GPs and nurses on categorical vari-
ables were analyzed using 2 Χ 2 χ2- tests (e.g., Hypothesis
1), while two-sample t-tests were used for continuous
variables (e.g., Hypothesis 2, Hypothesis 3). When
Levene’s test for equality of variances indicated that the
variances between GPs and nurses responses were signifi-
cantly different, a two-sample t-test was performed that
did not assume equal variances. Logistic regressions using
a generalized linear function examined the prediction of
service provision (Hypothesis 4; 0 = none, 1 = at least once;
reference category= 0). Before conducting the logistic
regressions, zero-order correlations were conducted to
determine which variables were appropriate for model
inclusion. Only items statistically significant at the uni-
variate level were included at the multivariate level. Thesignificance level for all statistical tests was set at p< 0.01
to reduce Type I errors associated with multiple testing.
Results
Overview of the study sample
Table 1 contains summary data for cannabis-related
training and exposure to cannabis users. GPs were sig-
nificantly more likely to not have any personal experience
with cannabis use compared to nurses (p< 0.001), while
nurses were more likely to have a relative (p< 0.001) or
know a friend (p< 0.001) who regularly uses cannabis.
Further, GPs were significantly more likely to have
received a small amount of training in cannabis-related
issues (p= 0.006), while nurses were more likely to have
not received any cannabis-related training (p< 0.001).
Knowledge about Cannabis use and its treatment
As set out in Table 2, GPs were more likely than nurses
to have agreed that effective psychological treatments
exist for reducing cannabis use (p= 0.001) and that can-
nabis users are more likely to have a mental health prob-
lem than non-cannabis users (p< 0.001). Further, 34%
(n= 221) of health practitioners somewhat or completely
agreed that effective pharmacological treatments exist
for cannabis use.
On average, GPs believed that 21% (SD= 21.58) of
people who try cannabis will someday develop cannabis
dependence, which was significantly less than nurses
believed (M= 25%, SD= 21.58), t(131.51) = -1.14,
p= 0.001. Of the 516 participants who responded to this
item, only 24% (n= 126) responded with an estimate
close to 9% (6-12%) [6,7]. Twenty-one percent of partici-
pants did not answer the question.
Table 2 Knowledge and Beliefs about Cannabis Use and its Treatment
Item Disagree completely Somewhat disagree Neutral Somewhat agree Agree completely t df
n (%) n (%) n (%) n (%) n (%)
Knowledge
Cannabis users are more likely to have a mental health problem than those who do not use cannabis
GPs (N= 502) 4 (<1%) 11 (2%) 19 (4%) 159 (32%) 309 (62%)
Nurses (N= 160) 4 (3%) 6 (4%) 20 (13%) 64 (40%) 66 (41%) 4.54** 224.80
Effective psychological treatments exist for helping people to reduce their cannabis use
GPs (N= 501) 9 (2%) 31 (6%) 118 (23%) 196 (39%) 147 (29%)
Nurses (N= 159) 7 (4%) 14 (9%) 42 (26%) 73 (46%) 23 (14%) 3.49** 658
Effective pharmacological treatments exist for assisting with cannabis withdrawal
GPs (N= 499) 43 (9%) 93 (19%) 195 (39%) 116 (23%) 52 (10%)
Nurses (N= 159) 11 (7%) 20 (13%) 75 (47%) 41 (26%) 12 (8%) -0.65 656
Withdrawal can be a barrier to quitting cannabis
GPs (N= 500) 10 (2%) 23 (5%) 67 (13%) 220 (44%) 180 (36%)
Nurses (N= 158) 2 (<1%) 3 (2%) 32 (20%) 71 (45%) 50 (32%) 0.44 656
Role Legitimacy
Conducting a 10 minute brief assessment of someone’s cannabis use can lead to reductions in their use
GPs (N= 501) 22 (4%) 24 (5%) 105 (21%) 210 (42%) 140 (28%)
Nurses (N= 159) 31 (20%) 26 (!6%) 37 (23%) 47 (30%) 18 (11%) 7.72** 223.44
People in my position are effective in treating patients with cannabis use problems
GPs (N= 499) 22 (4%) 60 (12%) 103 (21%) 218 (44%) 96 (19%)
Nurses (N= 160) 23 (14%) 36 (23%) 52 (33%) 38 (24%) 11 (7%) 7.64** 657
People in my position should receive education about cannabis
GPs (N= 501) 1 (<1%) 1 (<1%) 14 (3%) 116 (23%) 369 (74%)
Nurses (N= 160) 0 (0%) 1 (<1%) 6 (4%) 43 (27%) 110 (69%) 1.20 659
Note. *p< 0.01, **p≤ 0.001.
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Nurses reported significantly less role legitimacy about
providing cannabis-related services. Compared to nurses,
GPs more strongly agreed that conducting a 10-minute
brief assessment of someone’s cannabis use can lead to
reductions in cannabis use (p< 0.001) and that people in
their position are effective in treating patients with can-
nabis use problems (p< 0.001). Almost all GPs and
nurses agreed that people in their position should receive
education regarding cannabis (See Table 2).
Self-assessment of knowledge and skills
Few GPs and nurses felt confident in their knowledge
and skills about cannabis use and its treatment. As
shown in Table 3, GPs rated their knowledge about can-
nabis (p< 0.001), and their skills in screening (p< 0.001)
and managing cannabis use (p< 0.001), higher than
nurses rated their own knowledge and skills.
Policy attitudes
A significantly greater percentage of GPs than nurses
reported that cannabis use should be illegal, χ2(1) = 14.59,
p< 0.001, and a significantly greater percentage of nursesthan GPs reported that cannabis should be available for
medicinal purposes, χ2(1) = 30.11, p< 0.001, as shown in
Figure 1.
Screening, intervention, and referral
In the previous month, GPs reported screening an aver-
age of 3.84 (SD= 7.82, n= 498) patients for cannabis use
and treating an average of 1.71 (SD= 4.17, n= 500)
patients for cannabis use; although, approximately half
(46%, n= 230) had not engaged in any screening or
intervention provision (51%, n= 254). Nurses reported
screening an average of 2.22 (SD= 10.00, n= 158)
patients for cannabis use and treating an average of 1.33
(SD= 8.40, n= 159) patients for cannabis use in the last
month. Most nurses, however, had not screened (85%,
n= 134) or provided an intervention to any patients for
cannabis use (87%, n= 139). In addition, GPs and nurses
had referred less than one patient in the last month to
an alcohol and other drug (AOD) facility (GPs: M= 0.48,
SD= 1.42, n= 500, 374 (75%) had not engaged in referral;
Nurses: M= 0.84, SD= 4.62, n= 160, 139 (87%) had not
engaged in referral) or to a mental health service (GPs:
M= 0.76, SD= 1.78, n= 500, 318 (64%) had not engaged
Table 3 Self-Assessment of Knowledge about Cannabis Use and Skills Related to Screening and Managing Cannabis
Use
Item Very poor Poor Acceptable Strong Very strong t df
n (%) n (%) n (%) n (%) n (%)
Knowledge about Cannabis
GPs (N= 501) 35 (7%) 241 (48%) 209 (42%) 14 (3%) 2 (<1%) 3.85** 658
Nurses (N= 159) 30 (19%) 76 (48%) 49 (31%) 4 (3%) 0 (0%)
Skills in Screening for Cannabis Use
GPs (N= 499) 51 (10%) 241 (48%) 187 (37%) 18 (4%) 2 (<1%) 7.32** 654
Nurses (N= 157) 57 (36%) 68 (43%) 29 (18%) 3 (2%) 0 (0%)
Skills in Managing Cannabis Use
GPs (N= 495) 57 (12%) 300 (61%) 127 (26%) 9 (2%) 2 (<1%)
Nurses (N= 156) 55 (35%) 85 (54%) 15 (10%) 1 (<1%) 0 (0%) 7.13** 649
Note. *p< 0.01, **p≤ 0.001.
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had not engaged in referral). GPs were statistically signifi-
cantly more likely to have engaged in screening (χ2(1) =
72.45, p< 0.001), treatment (χ2(1) = 64.85, p< 0.001), and
referral (AOD: χ2(1) = 10.21, p=0.001; Mental Health:
χ2(1) = 38.24, p< 0.001) at least once (versus not at all)
compared to nurses.
In order to identify if any variables had a unique pre-
dictive variance regarding increased provision of screen-
ing or intervention for cannabis use, only variables
correlated with screening, intervention, and referral to
AOD or mental health services at a significance level less
than 0.01 were entered into the logistic regression mod-
els (Table 4). Interaction terms between health profes-
sion and other predictor variables were examined;
however, as none were significant they were not included
in the reported models. When the significant univariate
correlates were included in the regressions, profession
remained a significant predictor of screening, interven-
tion and referral to mental health services. GPs were**
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
Illegal Decrimina
Figure 1 This figure illustrates GP’s and nurses’ percentage agreemen4.73 times more likely to have engaged in screening
provision than nurses, were 4.22 times more likely to
have provided an intervention, and were 3.47 times
more likely to have referred someone to a mental health
service, after controlling for other predictors.
Confidence in the provision of screening was import-
ant, with every unit increase in perceived screening skills
associated with a 3.28 times greater chance of having
engaged in screening provision in the previous month
and an 8.69 times greater chance of having referred a
patient to an AOD service. Neither the degree of train-
ing, knowledge, nor perceived skills in cannabis inter-
vention, however, offered a significant unique prediction
of screening, intervention, or referral.
Health professionals who had a friend who regularly
used cannabis were 1.80 to 1.83 times more likely to
have referred someone to an AOD or mental health ser-
vice than those without such a friend. In regards to atti-
tudes, participants who believed cannabis should not be
available for medicinal purposes were 2.06 times more**
lised Available for Medicinal
Purposes
GPs
Nurses
t with three different cannabis use policy options.
Table 4 Binary Logistic Regressions Estimating Screening, Intervention, and Referral Provision in the Previous Month
Screening Intervention Referral to AOD Services Referral to Mental Health Services
Item Wald Χ2 OR 99% CI Wald Χ2 OR 99% CI Wald Χ2 OR 99% CI Wald Χ2 OR 99% CI
Professiona 24.07* 4.73 2.54, 8.79 22.30* 4.22 2.32, 7.67 4.64 1.88 1.06, 3.34 15.52* 3.47 1.87, 6.43
Cannabis Should not be Illegalb – – – – – – – – – 5.61 0.57 0.36, 0.91
Cannabis Should not be
Decriminalizedb
0.03 1.04 0.64, 1.70 – – – – – – – – –
Cannabis Should not be Available
for Medicinal Purposesb
7.97* 2.06 1.25, 3.41 1.88 1.34. 0.88, 2.02 – – – 0.22 1.13 0.68, 1.86
No Regular User Friendc 6.26 0.55 0.35, 0.88 3.22 0.67 0.44, 1.04 7.45* 0.55 0.35, 0.84 7.19* 0.56 0.36, 0.85
Training 2.35 1.33 0.93, 1.90 4.15 1.42 1.01, 1.98 1.25 1.22 0.86, 1.72 0.39 1.11 0.80, 1.55
Perceived Knowledge 0.00 1.00 0.65, 1.53 0.46 1.15 0.77, 1.71 2.37 0.72 0.47, 1.09 0.54 1.16 0.78, 1.75
Perceived Screening Skills 31.79* 3.28 2.17, 4.95 4.28 1.46 1.02, 2.09 8.69* 1.79 1.22, 2.65 4.54 1.49 1.03, 2.16
Perceived Management Skills 1.82 1.38 0.87, 2.20 3.13 1.47 0.96, 2.26 0.70 1.21 0.78, 1.88 1.14 1.27 0.82, 1.95
10 Minute Brief Assessment Can
Reduce Use
1.09 1.11 0.91, 1.36 2.70 1.17 0.97, 1.42 – – – – – –
Effective Psychological
Treatments Exist
1.03 1.12 0.90, 1.38 0.17 1.04 0.85, 1.28 2.06 1.17 0.94, 1.45 – – –
People in My Position Are Effective 0.46 0.93 0.76, 1.14 0.65 1.08 0.89, 1.31 – – – 0.42 1.06 0.88, 1.28
Note. -- indicates a variable not included in a model. Superscripts represent the reference group for each independent variable: a GPs, b Should be. . . (illegal, decriminalized, or available for medicinal purposes), c Has a
friend who is a regular cannabis user. * p< 0.01.
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Table 5 Barriers and Facilitators for Cannabis Use Screening and Intervention (N=664)
Statement GPs agreement n (%) Nurses agreement n (%) χ2(1)
Barriers
Do not have the skills to screen or provide an intervention 336 (67%) 124 (77%) 5.94
Cannabis use often is not the most important issue that needs
to be addressed during a patient’s visit
286 (57%) 56 (35%) 23.80**
Patients may not be receptive to screening or intervention 279 (55%) 98 (61%) 1.45
Do not have time to screen or provide an intervention 242 (48%) 41 (25%) 25.56**
Do not have support from colleagues/organization to screen or
provide an intervention
138 (27%) 55 (34%) 2.68
The effort required to motivate a cannabis user to quit is not
justified by the likelihood of a positive outcome
101 (20%) 15 (9%) 9.80*
Do not have a personal interest in providing screening or
treatment for cannabis use
95 (19%) 12 (7%) 11.78**
Do not have professional interest in providing screening or
treatment for cannabis use
77 (15%) 13 (8%) 5.45
I do not want to attract more cannabis users to my clinic 76 (15%) 5 (3%) 16.41**
Most people who use cannabis do not need screening or treatment 30 (6%) 7 (4%) 0.61
Cannabis users are unpleasant to work with 24 (5%) 3 (2%) 2.64
Cannabis users should only be treated by specialists in the field 15 (3%) 18 (11%) 17.36**
Facilitators
More training 408 (81%) 144 (89%) 6.03
Access to up-to-date management guidelines and recommendations 396 (79%) 130 (81%) 0.30
Having more options for referrals 391 (78%) 88 (55%) 32.31**
Having more resources to assist me (e.g., web interventions) 315 (63%) 103 (81%) 0.10
Believing that screening and intervention would lead to positive outcomes 232 (46%) 67 (42%) 1.00
Believing that screening and intervention are clinically important 134 (27%) 51 (32%) 1.54
Nothing would facilitate the screening or intervention of cannabis use 6 (1%) 2 (1%) <0.01
Note. *p< 0.01, **p≤ 0.001.
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it should be available. While that attitude was a signifi-
cant univariate correlate of intervention and referral to a
mental health service, it did not provide a unique predic-
tion of those actions.
Barriers and facilitators
As shown in Table 5, GPs more often than nurses
reported not having enough time for screening and
intervention provision (p< 0.001), not being personally
interested in screening and treatment provision
(p= 0.001), not believing that cannabis use is the most
important clinical issue (p< 0.001), not wanting to at-
tract more cannabis users to their clinic (p< 0.001), and
believing that the effort required to motivate a cannabis
user to quit is not justified by the likelihood of a positive
outcome (p< 0.002). Nurses more often reported that
cannabis users should only be treated by specialists in
the field (p< 0.001). In respect to facilitators, GPs more
so than nurses reported that having more referral
options would facilitate their provision of screening and
intervention for cannabis use (p< 0.001).Discussion
This study evaluated GP’s and nurses’ perceived know-
ledge, beliefs, and behaviors toward cannabis use and
its screening and management. As a whole, the findings
suggest that despite GPs and nurses having little to no
training in cannabis-related issues, most are aware of
basic treatment-related issues and believe that it is part
of their role to be educated about cannabis use. Yet,
many GPs and nurses believed their knowledge about
cannabis use and their skills in screening and managing
cannabis use to be poor. The findings also suggest that
nurses may be less knowledgeable about cannabis use
and feel less role legitimacy for its screening and treat-
ment. Thus, it is not surprising that being a GP was con-
sistently associated with cannabis service provision
compared with being a nurse. When controlling for
other relevant variables, GPs were three to five times
more likely than nurses to have engaged in screening,
brief intervention, and referral to mental health services.
Study findings also indicate that policy attitudes, per-
sonal experience, and perceived screening skills may
influence service provision.
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knowledgeable and to have less role legitimacy than GPs
is consistent with alcohol use research [16,25]. While
GPs rated their knowledge and skills better than did
nurses, it is important to note that less than half of GPs
considered their knowledge and screening skills to be ac-
ceptable to very strong and less than one-third consid-
ered their skills in managing cannabis use to be
acceptable to very strong. In addition, only a quarter of
GPs and nurses reported an accurate estimate of the
chance of developing dependence [6,7]. As 21% of parti-
cipants did not answer the question, 24% may overesti-
mate the actual rate of accurate responses, as those who
did not know the accurate figure may have chosen to
skip this item. Both GPs and nurses also overestimated
the effectiveness of pharmacological treatments [31].
These findings indicate that even though nurses may
benefit from training in cannabis-related issues more so
than GPs, training also has the potential to improve GP’s
service provision to cannabis users.
Consistent with previous research [18,20-22], GPs and
nurses identified not having enough skills, patients not
being receptive, and not having enough time as common
reasons for not engaging in screening and intervention
for cannabis use. Not believing that cannabis use is the
most important issue was a new common barrier identi-
fied in this study. Given that more GPs than nurses
endorsed this barrier, it is not surprising that GPs were
more likely than nurses to report not having enough
time and that having more referral options would facili-
tate their service provision. These findings suggest that
GPs may see more legitimacy for their role in screening
than they do intervention provision. As this study did
not examine health practitioners’ beliefs about their role
legitimacy for screening, future research would benefit
from examining role legitimacy beliefs for both screen-
ing and intervention provision.
Prior to this study, scant research had statistically
examined whether personal views and experience with
cannabis use influenced service provision. An exception
is Johnson and colleagues’ study [18], which found that
primary care physicians who had family and friends with
substance use problems had less difficulty discussing
substance use with patients. The current study found
that having a friend who regularly uses cannabis
increased referral provision, but not screening and inter-
vention provision. This study also identified that com-
pared to health practitioners who believed that cannabis
should be available for medicinal purposes, those who
believed cannabis should not be available for medicinal
purposes were twice as likely to have screened a patient
for cannabis use. Along with Lock and colleagues’ [21]
finding that nurses’ beliefs about alcohol’s perceived ben-
efits affect their willingness to provide alcohol-relatedservices, these findings suggest that training in cannabis-
related issues should incorporate discussions on the ef-
fectiveness of cannabis for medicinal purposes and how
personal experience can shape their professional behav-
ior. Doing so may help to motivate all health practi-
tioners to engage in evidenced-based service provision.
Implications for policymakers and educators
General practitioners and nurses represent the over-
whelming majority of primary care providers in Australia.
They have enormous potential to reach a broad range of
people for early intervention, where the focus is on pre-
vention and health promotion. Although Australian GPs
are being encouraged via government reimbursement
schemes to provide brief advice in many prevention
areas, including drug and alcohol use [13], efforts to in-
crease service provision for cannabis users may need to
be directed at both nurses and GPs, in order to utilize
the opportunity for collaboration between GPs and
nurses in the primary care setting. There are several rea-
sons why nurses should be involved in this process.
First, nurses were consistently less likely to have
engaged in service provision than GPs. Second, GPs in
this study were substantially more likely to identify bar-
riers to service provision that are difficult to resolve,
such as not having enough time and cannabis use not
being the most important issue. Third, in 2010 the Aus-
tralian Government announced a $523 million invest-
ment in Australia’s nurses in order reduce GP’s clinical
burden [32]. Such an investment increases the need to
improve nurses’ skills to ensure that they are fully able
to undertake effective preventive health activities. Al-
though the aim of the initiative is to allow GPs to focus
on diagnosis, while nurses focus on tasks such as care
co-ordination, health assessments, and health education
[32], the most suitable model of practice for nurses has
not been established. Thus, when developing training
models, researchers will need to keep in mind that
nurses may be operating from a substitution model
(only doing those tasks delegated to them) or from a
collaborative model (working autonomously within a
practice). In addition, researchers will need to find an
effective method for resolving the low legitimacy that
nurses feel for managing cannabis use.
Hence, part of a training strategy may require educa-
tion and empowerment of nurses in terms of their clin-
ical potential to assist in managing cannabis use
problems. In a substitution model, it may be advanta-
geous to educate both GPs and nurses in how best to
utilize their respective clinical strengths. This might in-
volve nurses performing the screening and assessment of
patients’ readiness for change and then referring moti-
vated patients on to GPs for a brief intervention. GPs
may develop clinical plans that involve utilizing nurses
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to remain in the referral process, but minimize their
clinical burden, while appropriately managing patients
concerns. In those circumstances where nurses and
nurse practitioners are working in a relatively autono-
mous context, nurses could be trained in both screening
and intervention, referring to the GP only when the ex-
tremity of clinical features might warrant it.
Regardless of whom efforts are focused on, combining
motivational interviewing with screening and interven-
tion training for cannabis use may lead to greater
provision of services to individuals who use cannabis.
Research has found that motivating GPs to provide an
intervention does not need to involve long professional
development sessions. For example, a 20-minute motiv-
ational discussion with GPs has substantially increased
their likelihood of discussing methods for managing
dependent cannabis users [30]. Such motivational train-
ing may circumvent the negative effect that health prac-
titioners’ pre-existing low motivation has on service
provision. Providing GPs with training and support has
been found to only increase provision of alcohol screen-
ing and brief advice for those GPs who were already
motivated to work with patients with alcohol problems
prior to receiving training [28]. Almost all GPs and
nurses in the current study reported it was part of their
role to receive education about cannabis use, and over
three-fourths reported that receiving more training
would increased their service provision. As such, provid-
ing training in screening (that includes information
about screening resources, practice guidelines, and refer-
ral options) and in brief motivational interventions (that
includes information about treatment resources, and dis-
cussion of personal experience and medicinal cannabis
use) during professional development seminars may in-
crease service provision for cannabis users.
When evaluating the effects of training on GPs’ and
nurses’ service provision, researchers should carefully
monitor increases in knowledge and attitudes toward ser-
vice provision. Previous research found that training in a
brief intervention led to increases in the understanding
of a brief intervention for nurses, but not GPs [33]. Fur-
thermore, while nurses’ knowledge about alcohol
increased as a result of training, their positive attitudes
towards discussing alcohol with patients decreased.
Thus, training needs to be carefully developed and admi-
nistered to avoid potential negative consequences.
Strengths and limitations
The strength of the study is its large sample size. Limita-
tions include the sole recruitment of health practitioners
from Healthed seminars, reliance on self-reports of ser-
vice provision, using a survey without established psy-
chometric properties, and the low response rate (35%).Notably, the obtained survey response rate was similar
to other surveys conducted with Australian GPs [34,35],
and thus, may not be indicative of non-respondents
being less interested in cannabis use than responders.
An additional limitation of this study is the high amount
of missing data regarding the percentage of patients who
will develop dependence (21% missing data). Research
suggests that the high nonresponse on this item may
have been due to the cognitively demanding nature of
the question [36]. In order to reduce the non-response
rate for this item, future researchers may want to adapt
the open-ended item to include response options. Lastly,
respondents were not provided with operational defini-
tions for screening, brief interventions, or referrals; there-
fore, these items may have been interpreted differently.
In light of these limitations, results may only generalize
to GPs and nurses interested in women’s and children’s
health who also have an interest in contributing to
research. Future research with professionals interested
in men’s health and that uses operational definitions and
a validated survey may obtain different results.Conclusions
This study found that as a group, GPs and nurses perceive
their knowledge and skills pertaining to cannabis-related
issues to be poor. In addition, this study identified that
health professionals’ occupation, attitudes, personal ex-
perience, and skills may affect their provision of cannabis-
related care. Education and training, therefore, may be
particularly important to improving service provision for
individuals who use cannabis, especially training that uti-
lizes the complementary roles that each professional
plays in general practice, with a special emphasis on in-
creasing nurses’ knowledge, skills, and role legitimacy.
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GPs: General Practitioners.
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